tiprankstipranks
Trending News
More News >
CordovaCann Corp. (TSE:CDVA)
:CDVA

CordovaCann (CDVA) AI Stock Analysis

Compare
0 Followers

Top Page

TSE:CDVA

CordovaCann

(CDVA)

Select Model
Select Model
Select Model
Underperform 38 (OpenAI - 5.2)
Rating:38Underperform
Price Target:
C$0.02
▼(-5.00% Downside)
The score is driven primarily by weak financial health (loss-making operations, declining gross margin, and negative equity/high leverage). Technicals add further pressure as the stock trades well below key moving averages with negative MACD and deeply oversold momentum. Valuation metrics provide limited support due to the negative P/E and missing dividend yield.
Positive Factors
Revenue Growth
The company's revenue growth indicates expanding market presence and demand for its products, which is crucial for long-term sustainability in the competitive cannabis industry.
Cash Generation Efficiency
Efficient cash generation relative to earnings suggests strong operational management, providing a foundation for reinvestment and growth opportunities.
Market Position
The company's integrated operations across the cannabis supply chain enhance its market position, allowing it to capture value at multiple stages and respond flexibly to market demands.
Negative Factors
Profitability Concerns
Ongoing lack of profitability and declining margins indicate challenges in cost management and pricing power, which could hinder long-term financial health and competitiveness.
Balance Sheet Weakness
A fragile balance sheet with high leverage poses solvency risks, limiting financial flexibility and increasing vulnerability to economic downturns or operational disruptions.
Cash Flow Challenges
Challenges in sustaining cash flow growth highlight potential difficulties in meeting operational and investment needs, impacting long-term growth prospects.

CordovaCann (CDVA) vs. iShares MSCI Canada ETF (EWC)

CordovaCann Business Overview & Revenue Model

Company DescriptionCordovaCann Corp. engages in identifying, funding, developing, and managing operations in the cannabis value chain business. As of February 14, 2022, it operated 14 stores under the Star Buds Cannabis Co. brand in Ontario, Manitoba, Alberta, and British Columbia, Canada, as well as Oregon and Washington, the United States. The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. is headquartered in Toronto, Canada.
How the Company Makes MoneyCordovaCann generates revenue through multiple key streams, primarily from the sale of its cannabis products, which include both wholesale and retail offerings. The company cultivates its own cannabis and processes it into various forms, allowing for direct sales to consumers and partnerships with dispensaries and retailers. Additionally, CordovaCann may benefit from licensing agreements and collaborations with other companies in the cannabis space, enhancing its market reach and product offerings. The company's focus on quality and compliance also positions it to capitalize on the expanding legal cannabis market, contributing to its earnings through increased consumer demand.

CordovaCann Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
BreakdownTTMDec 2025Dec 2024Dec 2024Dec 2022Dec 2022
Income Statement
Total Revenue13.57M14.25M13.80M13.53M13.59M
Gross Profit3.48M1.55M4.08M3.73M3.86M
EBITDA-548.88K-817.35K493.74K-1.85M-4.68M
Net Income-5.47M-2.69M-1.49M-3.96M-6.88M
Balance Sheet
Total Assets9.79M6.41M9.55M16.75M10.26M
Cash, Cash Equivalents and Short-Term Investments534.80K598.20K552.47K714.83K248.42K
Total Debt5.81M5.00M6.21M6.08M6.38M
Total Liabilities11.98M11.61M12.15M10.16M11.29M
Stockholders Equity-2.94M-5.81M-3.30M5.86M-1.72M
Cash Flow
Free Cash Flow1.14M1.12M1.49M-2.73M-1.21M
Operating Cash Flow1.30M1.14M1.49M-2.07M-452.73K
Investing Cash Flow40.38K1.55M52.96K2.07M-708.88K
Financing Cash Flow-1.05M-2.51M-1.10M720.69K-134.36K

CordovaCann Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
45
Neutral
C$3.66M-3.9064.22%
44
Neutral
C$4.95M-2.70-150.44%55.74%-27.59%
39
Underperform
C$4.58M-0.18
38
Underperform
C$3.84M-1.331.60%-213.10%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CDVA
CordovaCann
0.04
>-0.01
-12.50%
TSE:BBM
Blueberries Medical
0.01
>-0.01
-33.33%
TSE:CFT
Craftport Cannabis Corp
0.05
0.00
0.00%
TSE:BAMM
Body & Mind
0.03
<0.01
25.00%
TSE:CVGR
City View Green Holdings
0.08
-0.02
-19.19%
TSE:FFNT
4Front Ventures
0.01
>-0.01
-33.33%

CordovaCann Corporate Events

Other
CordovaCann Corp. Announces Auditor Change
Neutral
Oct 28, 2025

CordovaCann Corp., a cannabis-focused consumer products company, has announced a change in its auditor, appointing Horizon Assurance LLP as the new auditor effective October 13, 2025. This change was amicable, with no disagreements or unresolved issues with the former auditor, DNTW Toronto LLP, and is part of the company’s routine governance processes.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 31, 2025